Pharmaceutical care and community pharmacists' understanding of bisphosphonate dosing information

Journal of Clinical Pharmacy and Therapeutics

Volumn 29, Issue 6, 2004, Pages 531-536

  Li, Wilson W ^a,b   Kendler, D L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Osteoporosis Research Centre   (Canada)

Author keywords

Alendronate; Bisphosphonate; Etidronate; Osteoporosis; Pharmaceutical care; Risedronate

Indexed keywords

ALENDRONIC ACID; ANTACID AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ETIDRONIC ACID; RISEDRONIC ACID; VITAMIN;

CANADA; CONFERENCE PAPER; CONTINUING EDUCATION; DOSE CALCULATION; PHARMACEUTICAL CARE; PHARMACIST; POSTMENOPAUSE OSTEOPOROSIS; QUESTIONNAIRE;

ALENDRONATE; COMMUNITY PHARMACY SERVICES; DIPHOSPHONATES; DRUG ADMINISTRATION SCHEDULE; DRUG INFORMATION SERVICES; EDUCATION, PHARMACY, CONTINUING; ETIDRONIC ACID; FEMALE; HUMANS; KNOWLEDGE; MALE; PHARMACISTS; QUESTIONNAIRES;

EID: 10844260498     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2004.00597.x     Document Type: Conference Paper

References (20)

1. De Groen PC, Lubbe DF, Hirsch LJ et al. (1996) Esophagitis associated with the use of alendronate. New England Journal of Medicine, 335, 1016-1021.
2. Adami S, Zamberlan N (1996) Adverse effects of bisphosphonates. Drug Safety, 14, 158-170.
3. Bauer DC, Black D, Ensrud K et al. (2000) Upper gastrointestinal tract safety profile of alendronate: The Fracture Intervention Trial. Archives of Internal Medicine, 160, 517-525.
4. Schnitzer T, Bone HG, Crepaldi G et al. (2000) Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Aging Clinical and Experimental Research, 12, 1-12.
5. Miller PD, Woodson G, Licata AA et al. (2000) Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms. Clinical Therapeutics, 22, 1433-1442.
6. Committee on Safety of Medicines. (1996) Oesophageal reactions with alendronate sodium (Fosamax). Current Problems in Pharmacology, 22, 5.
7. Castell DO. (1996) 'Pill esophagitis' - the case of alendronate. New England Journal of Medicine, 335, 1058-1059.
8. Ford S, Jones K. (1995) Integrating pharmacy fully into the primary care team: much to recommend it. British Medical Journal, 310, 1620-1621.
9. Srnka QM. (1998) Pharmacists as self-care consultants. Journal of American Pharmaceutical Association, 38, 235.
10. Knapp DA. (1979) Barriers faced by pharmacists when attempting to maximize their contribution to society. American Journal of Education, 43, 357-359.
11. McDonough RP, Rovers JP, Currie JD, Hagel H, Vallandingham J, Sobotka J. (1998) Obstacles to the implementation of pharmaceutical care in the community setting. Journal of American Pharmaceutical Association, 38, 87-95.
12. Christensen DB, Hansen RW. (1999) Characteristics of pharmacists associated with the provision of cognitive services in the community setting. Journal of American Pharmaceutical Association, 39, 640-649.
13. Raisch DW. (1993) Barriers to providing cognitive services. American Pharmacy, NS33, 54-58.
14. Miller MJ, Ortmeier BG. (1995) Factors influencing the delivery of pharmacy services. American Pharmacy, NS35, 39-45.
15. Sisson EM, Israel MK. (1996) Extent of community-based delivery of pharmaceutical care in Virginia. Pharmacotherapy, 16, 94-102.
16. Odedina FT, Segal R. (1996) Behavioral pharmaceutical care scale for measuring pharmacists' activities. American Journal of Health-System Pharmacy, 53, 855-865.
17. Hepler CD, Strand LM. (1990) Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy, 47, 533-543.
18. Lipton HL, Byrns PJ, Soumerai S, Chrischilles EA. (1995) Pharmacists as agents of change for rational drug therapy. International Journal of Technology Assessment in Health Care, 11, 485-508.
19. Hatoum HT, Akhras K. (1993) 1993 bibliography: a 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists. The Annals of Pharmacotherapy, 27, 1106-1119.
20. Tett SE, Higgins GM, Armour CL. (1993) Impact of pharmacist interventions on medication management by the elderly: a review of the literature. The Annals of Pharmacotherapy, 27, 80-86.